Leading methodologist working at the intersection of statistics, evidence synthesis, and health economics. He has over 20 years of research experience to understand the clinical and economic value of novel health technologies, supporting drug development, market access decisions, and health technology assessment. His work has been highly cited and established him as a thought leader in HEOR.